Kosta Kleyman is the portfolio manager for the Seligman Healthcare Spectrum Strategy.  Kosta joined the Seligman Investments team at Columbia Threadneedle Investments in 2023 as a senior portfolio analyst focusing on biotechnology and pharmaceuticals. Prior to that Kosta was an analyst in Central Research at Columbia Threadneedle Investments and was responsible for the Therapeutics vertical coverage. Before joining Columbia Threadneedle in 2020, he was a biotech investment analyst at Acuta Capital Partners. In addition, he held product management, business development, and lifecycle strategy & clinical development roles at Genentech, AstraZeneca, and Allergan. Kosta has been a member of the finance industry since 2019 and the healthcare industry since 2009. He studied Finance as well as received a Doctorate of Pharmacy from the University of Georgia.